Journal of Medicinal Chemistry · 2005 · 39 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingProtein StructureProteolytic EnzymesStructure-activity Relationship AnalysisAntimalarial AgentsAntimalarial Drug DevelopmentAspartic ProteasesCrystal Structure AnalysisEnzyme ActivityNovel Antiparasitic Compound ClassesPlasmodium FalciparumProtease Inhibitors
New and potent inhibitors of the malarial aspartic proteases plasmepsin (Plm) I and II, from the deadliest malaria parasite Plasmodium falciparum, have been synthesized utilizing Suzuki coupling reactions on previously synthesized bromobenzyloxy-substituted statine-like inhibitors. The enzyme inhibition activity has been improved up to eight times by identifying P1 substituents that effectively bind to the continuous S1-S3 crevice of Plasmepsin I and II. By replacement of the bromo atom in the P1 p-bromobenzyloxy-substituted inhibitors with different aryl substituents, several inhibitors exhibiting K(i) values in the low nanomolar range for both Plm I and II have been identified. Some of these inhibitors are also effective in attenuating parasite growth in red blood cells, with the best inhibitors, compounds 2 and 4, displaying 70% and 83% inhibition, respectively, at a concentration of 5 microM. The design was partially guided by the X-ray crystal structure disclosed herein of the previously synthesized inhibitor 1 in complex with plasmepsin II.
16
Highly Active Palladium Catalysts for Suzuki Coupling Reactions
John P. Wolfe, Robert A. Singer, Bryant H. Yang et al. · Journal of the American Chemical Society · 1999 · 1.1K citations